[go: up one dir, main page]

UA101370C2 - Normal;heading 1;heading 2;heading 3;ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF - Google Patents

Normal;heading 1;heading 2;heading 3;ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

Info

Publication number
UA101370C2
UA101370C2 UAA201015023A UAA201015023A UA101370C2 UA 101370 C2 UA101370 C2 UA 101370C2 UA A201015023 A UAA201015023 A UA A201015023A UA A201015023 A UAA201015023 A UA A201015023A UA 101370 C2 UA101370 C2 UA 101370C2
Authority
UA
Ukraine
Prior art keywords
heading
methods
oral formulations
normal
cytidine analogs
Prior art date
Application number
UAA201015023A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джеффри Б. ИТТЕР
Мей Лай
Джей Томас БЕКСТРЕМ
Original Assignee
Селджин Корпорэйшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Селджин Корпорэйшн filed Critical Селджин Корпорэйшн
Priority claimed from PCT/US2009/002999 external-priority patent/WO2009139888A1/en
Publication of UA101370C2 publication Critical patent/UA101370C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
UAA201015023A 2008-05-15 2009-05-14 Normal;heading 1;heading 2;heading 3;ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF UA101370C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5360908P 2008-05-15 2008-05-15
PCT/US2009/002999 WO2009139888A1 (en) 2008-05-15 2009-05-14 Oral formulations of cytidine analogs and methods of use thereof

Publications (1)

Publication Number Publication Date
UA101370C2 true UA101370C2 (en) 2013-03-25

Family

ID=51585279

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201214281A UA111331C2 (en) 2008-05-15 2009-05-14 Pharmaceutical composition for oral administration containing 5-azacytidine
UAA201015023A UA101370C2 (en) 2008-05-15 2009-05-14 Normal;heading 1;heading 2;heading 3;ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201214281A UA111331C2 (en) 2008-05-15 2009-05-14 Pharmaceutical composition for oral administration containing 5-azacytidine

Country Status (1)

Country Link
UA (2) UA111331C2 (en)

Also Published As

Publication number Publication date
UA111331C2 (en) 2016-04-25

Similar Documents

Publication Publication Date Title
MY161593A (en) Oral formulations of cytidine analogs and methods of use thereof
MX2009001711A (en) Sustained-release formulations of topiramate.
UA104869C2 (en) Normal;heading 1;heading 2;heading 3;PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
WO2008028193A3 (en) Colon-targeted oral formulations of cytidine analogs
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
IL188172A0 (en) Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
MX346335B (en) Antisense compositions and methods of making and using same.
EA200970287A1 (en) METHODS, COMPOUNDS, COMPOSITIONS AND MEDIA SUITABLE FOR DELIVERY OF 3-AMINO-1-PROPANSULPHONE ACID
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
MX344787B (en) Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders.
TR201909277T4 (en) Rasagiline extended release formulations and uses.
PL1819227T3 (en) Pharmaceutical formulation of decitabine
UA102517C2 (en) Substituted morpholine and thiomorpholine derivatives, pharmaceutical composition based thereon and use thereof for the preparation of medicament for the treatment of a disorder or disease of the central nervous system
MY179527A (en) Catecholamine derivatives useful for the treatment of parkinson's disease
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
CY1115725T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS
MX2012001660A (en) Linaclotide-containing formulations for oral administration.
ZA200908928B (en) Formulations for the oral administration of therapeutic agents and related methods
TN2015000135A1 (en) Modified release formulations for oprozomib
MX2009010689A (en) Novel formulations for delivery of antiviral peptide therapeutics.
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
TW200716204A (en) Pharmaceutical composition
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same